AdaptHealth (AHCO) Change in Accured Expenses (2018 - 2026)
AdaptHealth's (AHCO) quarterly Change in Accured Expenses came in at $11.6 million in Q1 2026, up 156.08% year-on-year from $4.5 million in Q1 2025, and down 57.76% quarter-over-quarter from $27.5 million in Q4 2025.
AdaptHealth (AHCO) Change in Accured Expenses (2018 - 2026) Analysis & Trends
AdaptHealth's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 156.08% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $146.3 million, a 41.47% increase from a year earlier, with the FY2025 full-year figure at $139.3 million, up 311.66% from the prior year.
- Change in Accured Expenses declined to $11.6 million in Q1 2026 per AHCO's latest filing, from $27.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $110.3 million in Q2 2024 and bottomed at -$68.1 million in Q2 2023.
- The 5-year median for Change in Accured Expenses is $9.6 million (2022), against an average of $9.9 million.
- Biggest YoY gain for Change in Accured Expenses was 724.76% in 2022; the steepest drop was 290.56% in 2022.
- Year by year, Change in Accured Expenses stood at $9.6 million in 2022, then soared by 576.79% to $64.7 million in 2023, then tumbled by 94.59% to $3.5 million in 2024, then soared by 683.96% to $27.5 million in 2025, then tumbled by 57.76% to $11.6 million in 2026.
- Per Business Quant, the three latest AHCO Change in Accured Expenses figures stand at $11.6 million (Q1 2026), $27.5 million (Q4 2025), and $46.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 21.07 Mn |
| 10 | AdaptHealth | 1.48 Bn | 1.43 Bn | 111.50 Mn | 11.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 27.47 Mn |
| Dec 31, 2025 | 27.47 Mn |
| Sep 30, 2025 | 46.85 Mn |
| Sep 30, 2025 | 46.85 Mn |
| Jun 30, 2025 | 60.43 Mn |
| Jun 30, 2025 | 60.43 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Sep 30, 2024 | -14.86 Mn |
| Sep 30, 2024 | -14.86 Mn |
| Jun 30, 2024 | 110.27 Mn |
| Jun 30, 2024 | 110.27 Mn |
| Mar 31, 2024 | -65.08 Mn |
| Mar 31, 2024 | -65.08 Mn |
| Dec 31, 2023 | 64.74 Mn |
| Dec 31, 2023 | 64.74 Mn |